A Catalogue Beyond One RobotThin moat
Synektik (SNT) — moat facet
Synektik sells for a dozen manufacturers, and the second-largest supplies 6,8% of what the equipment segment buys.
Synektik is more than a da Vinci distributor, though not by as much as its catalogue suggests. It sells therapy devices from Carl Zeiss, Eckert & Ziegler, HistoSonics, Hologic, Insightec, ZAP Surgical and Medical Microinstruments, imaging from Philips, contrast injectors, and pharmacy automation from Becton Dickinson Rowa and Loccioni1. In the April-June 2026 quarter alone it installed two APOTECAchemo and two BD Rowa pharmacy systems, two angiographs and a Symani microsurgery system2. Hologic's mammography and biopsy products came under a three-year agreement from October 20243.
The purchases show the proportions. Intuitive was 80,2% of the equipment segment's purchases in the year to September 2025; the second-largest supplier was 6,8%4. Everything beyond the robot is a long tail of smaller products.
The catalogue matters for tenders. A hospital running a radiology or oncology tender can buy several things from one supplier, and each product keeps Synektik's sales force in the hospital.
The catalogue earns its keep in the tender list. In the year to September 2025 Synektik also announced material contracts for angiographs at hospitals in Przemyśl and Łomża and, in a consortium with Becton Dickinson, for pharmacy robots including BD Rowa Vmax and APOTECAchemo at the district hospital in Radomsko5. In January 2026 it added HistoSonics' Edison on an exclusive three-year agreement with an option for two more6.
A rising share for the second supplier would show the catalogue carrying more weight.
A broad catalogue with one dominant supplier.
How much weight the catalogue beyond the robot carries.
Source: Synektik annual management board report, year to September 2025 ↗- ReportedIt sells therapy devices from Carl Zeiss, Eckert & Ziegler, HistoSonics, Hologic, Insightec, ZAP Surgical and Medical Microinstruments, imaging from Philips, contrast injectors, and pharmacy automation from Becton Dickinson Rowa and Loccioni.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedIn the April-June 2026 quarter alone it installed two APOTECAchemo and two BD Rowa pharmacy systems, two angiographs and a Symani microsurgery system.Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
- ReportedHologic's mammography and biopsy products came under a three-year agreement from October 2024.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedIntuitive was 80,2% of the equipment segment's purchases in the year to September 2025; the second-largest supplier was 6,8%.Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedIn the year to September 2025 Synektik also announced material contracts for angiographs at hospitals in Przemyśl and Łomża and, in a consortium with Becton Dickinson, for pharmacy robots including BD Rowa Vmax and APOTECAchemo at the district hospital in Radomsko.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedIn January 2026 it added HistoSonics' Edison on an exclusive three-year agreement with an option for two more.Synektik management board report for the half-year 1 October 2025 - 31 March 2026 - including the HistoSonics Edison exclusive distribution agreement and the installed base at March 2026. — October 2025 - March 2026 · publ. June 2026 · source ↗